PREDATORY PUBLISHING PRACTICES: WHAT RESEARCHERS SHOULD KNOW BEFORE SUBMITTING THEIR MANUSCRIPT




Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Abstract Background Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes status.However, the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury (I/R) has not been fully understood.Methods Electron microscopy, western blots, immunofluorescence, qPCR, mutant plasmid

read more